GenBio

Executive Summary

GenBio is a fully integrated medical diagnostics company specializing in the development, manufacturing, and global distribution of in vitro diagnostic (IVD) test kits for infectious and autoimmune diseases. Founded in 1998 and headquartered in Salt Lake City, the company operates under U.S. FDA and ISO 13485 standards, ensuring high-quality and regulatory compliance. GenBio leverages intellectual property licenses from governments and academic institutions to deliver commercially viable diagnostic solutions. With a focus on serology products, the company addresses a growing demand for accurate, reliable diagnostic tools in both clinical and public health settings. Despite being a private entity with limited public financial disclosures, GenBio's long-standing presence and adherence to stringent regulatory frameworks position it as a credible player in the diagnostics market. The company's integrated business model—from R&D to distribution—provides competitive advantages in quality control and innovation, although its private status limits visibility into recent performance and growth trajectory.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance for New Autoimmune Disease Panel70% success
• Q2 2026Expansion of Distribution Network in Emerging Markets80% success
• TBDStrategic Partnership for Infectious Disease Diagnostics50% success